Acute Fatty Liver of Pregnancy.
Journal
Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
pubmed:
15
11
2019
medline:
10
6
2021
entrez:
15
11
2019
Statut:
ppublish
Résumé
Acute fatty liver of pregnancy (AFLP) is a rare, but potentially fatal condition, characterized by hepatic failure typically in the third trimester of pregnancy that is associated with multiorgan involvement resulting in a number of clinical and laboratory abnormalities. The cornerstone of management of AFLP includes prompt recognition, preparation for delivery, and supportive care such as reversal of coagulopathy. Early diagnosis, prompted delivery, and supportive care have resulted in improved maternal morbidity and mortality. This review focuses on the epidemiology, etiology, clinical presentation, diagnosis, management, and resolution of AFLP.
Identifiants
pubmed: 31725416
doi: 10.1097/GRF.0000000000000494
pii: 00003081-202003000-00019
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
152-164Références
Tarnier S. Note sur l’etat graisseux du foie dans la fievre peurperale. C R Soc Biol. 1857;3:209–214.
Lomer O. Ueber die Bedeutung des Icterus gravidarum, etc. Zeitschr f Geb u Gyn. 1886;xiii:169–185.
Williams JW. Obstetrics: A Textbook for Students and Practitioners. London: D Appelton and Company; 1903:444.
Stander H, Cadden B. Acute yellow atrophy of the liver in pregnancy. Am J Obstet Gynecol. 1934;28:61–69.
Sheehan HL. The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Gynecol. 1940;47:49–62.
Lucke B. the pathology of fatal epidemic hepatitis. Am J Pathol. 1944;20:471–593.
Zondek B, Bromberg YM. Infectious hepatitis in pregnancy. J Mt Sinai Hosp N Y. 1947;14:222–243.
Sherlock S. Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut. 1983;24:265–269.
Burroughs AK, Seong NH, Dojcinov DM, et al. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med. 1982;51:481–497.
Reye RD, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood. Lancet. 1963;2:749–752.
Strauss AW, Bennett MJ, Rinaldo P, et al. Inherited long –chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol. 1999;23:100–112.
Browning MF, Levy HL, Wilkins-Haug LE, et al. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol. 2006;107:115–120.
Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340:1723–1731.
Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol. 1998;178:603–608.
Santos L, Patterson A, Moreea SM, et al. Acute liver failure in pregnancy associated with maternal MCAD deficiency. J Inhert Metab Dis. 2007;30:103.
Ylitalo K, Vanttinen T, Halmesmaki E, et al. Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency. Am J Obstet Gynecol. 2005;193:2060–2062.
Sims HF, Brackett JC, Powell CK, et al. The molecular basis of pediatric long chain 3-hydroxyacyl-Co-A dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA. 1995;92:841–845.
Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209:456.e1–456.e7.
Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;18:389–395.
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57:951–956.
Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut. 1994;35:101–106.
Lui J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112:838–846.
Monga M, Katz AR. Acute fatty liver in the second trimester. Obstet Gynecol. 1999;93:811–813.
Bacq Y. Liver disease unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenterol. 2011;35:182–193.
Davidson KM, Simpson LL, Knox TA, et al. Acute fatty liver of pregnancy in triplet gestation. Obstet Gynecol. 1998;91:806–808.
Chen H, Yuan L, Tan J, et al. Severe liver disease in pregnancy. Int J Gynaecol Obstet. 2008;101:277–280.
Vigil-de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med. 2011;24:1143–1146.
Nelson DB, Yost NP, Cunningham FG. Hemostatic dysfunction with acute fatty liver of pregnancy. Obstet Gynecol. 2014;124:40–46.
Ch’ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwester Wales. Gut. 2002;51:876–880.
Naoum EE, Leffert LR, Chitilian HV, et al. Acute fatty liver of pregnancy. Anesthesiology. 2019;130:446–461.
Kerr R, Newsome P, Germain L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost. 2003;1:754–759.
Cunningham FG, Lowe T, Guss S, et al. Erythrocyte morphology in women with severe preeclampsia and eclampsia. Preliminary observations with scanning electron microscopy. Am J Obstet Gynecol. 1985;153:358–363.
Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369:2525–2534.
Sibai BM. Imitators of severe preeclampsia. Obstet Gyncol. 2007;109:956–966.
Mabie WC. Acute fatty liver of pregnancy. Crit Care Clin. 1991;7:799–808.
Vigil-De Gracia P. Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders. Int J Gynecol Obstet. 2001;73:215–220.
Byrne JJ, Seasely A, McIntire DD, et al. Pragmatic acute fatty liver of pregnancy and HELLP syndrome on admission (abstract 863). Am J Obstet Gynecol. 2019;220:S561.
Byrne JJ, Seasely A, McIntire DD, et al. AFLP versus HELLP syndrome: pregnancy outcomes and recovery (abstract 563). Am J Obstet Gynecol. 2019;220:S375.
Critical care in pregnancy. ACOG Practice Bulletin No. 211. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2019;133:e303–e319.
American College of Obstetricians and Gynecologists: Hypertension in Pregnancy. Report of the American college of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131.
Lau HH, Chen YY, Huang JP, et al. Acute fatty liver of pregnancy in a Taiwanese tertiary care center: a retrospective review. Taiwan J Obstet Gynecol. 2010;49:156–159.
Mellouli MM, Amara FB, Maghrebi H, et al. Acute fatty liver of pregnancy over a 10-year period at a Tunisian tertiary care center. Int J Gynaecol Obstet. 2012;117:88–89.
Cheng N, Xiang T, Wu X, et al. Acute fatty liver of pregnancy: a retrospective study of 32 cases in South China. J Matern Fetal Neonatal Med. 2014;27:1693–1697.
Zhang YP, Kong WQ, Zhou SP, et al. Acute fatty liver of pregnancy: a retrospective analysis of 56 cases. Chin Med J (Engl). 2016;129:1208–1214.
Gao Q, Qu X, Chen X, et al. Outcomes and risk factors of patients with acute fatty liver of pregnancy: a multicenter retrospective study. Singapore Med J. 2018;59:425–430.
Ilham Aldika Akbar M, Sari I, Aditiawarman, et al. Clinical characteristics of acute fatty liver of pregnancy in a tertiary Indonesian hospital. J Matern Fet Neonatal Med. 2019;32:826–832.
Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology. 1985;5:1149–1158.
Wu Z, Huang P, Gong Y, et al. Treating acute fatty liver of pregnancy with artificial liver support therapy: systematic review. Medicine (Baltimore). 2018;97:e12473.
Martin JN, Briery NM, Rose CH, et al. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher. 2008;47:113–115.
Yu CB, Chen JJ, Du WB, et al. Effects of plasma exchange combined with continuous renal replacement therapy on acute fatty liver of pregnancy. Hepatobiliary Pancreat Dis Int. 2014;13:179–183.
Tang W, Huang Z, Wang Y, et al. Effect of plasma exchange on hepatocyte oxidative stress, mitochondria function, and apoptosis in patients with acute fatty liver of pregnancy. Artif Organs. 2012;36:E39–E47.
Ding J, Han LP, Lou XP, et al. Effectiveness of combining plasma exchange with plasma perfusion in acute fatty liver of pregnancy: a retrospective analysis. Gynecol Obstet Invest. 2015;79:97–100.
Kushner T, Tholey D, Dodge J, et al. Outcomes of liver transplantation for acute fatty liver disease of pregnancy. Am J Transplant. 2019;19:2101–2107.
de Naeyer S, Ysebaert D, van Utterbeeck M, et al. Acute fatty liver of pregnancy and molecular absorbent recirculating system (MARS)- therapy: a case report. J Matern Fetal Neonatal Med. 2008;21:587–589.
Saliba F. The molecular absorbent recirculating system (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care. 2006;10:118–120.
Moldenhauer JS, O’brien JM, Barton JR, et al. Acute fatty liver of pregnancy with pancreatitis: a life-threatening complication. Am J Obstet Gynecol. 2004;190:502–505.
Kennedy S, Hall PM, Seymour AE, et al. Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol. 1994;101:387–391.
Varner M, Rinderknecht NK. Acute fatty metamorphosis of pregnancy. A maternal mortality and literature review. J Reprod Med. 1980;24:177–180.
den Boer ME, Wanders RJ, Morris AA, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109:99–104.
Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: an experience in diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994;171:1342–1347.